Measles cases spread to three more states
Measles has spread to three more states as the outbreak reaches 800 confirmed cases across the U.S., the Centers for Disease Control and Prevention said.
Louisiana, Virginia and Missouri each confirmed their first cases over the weekend, with at least 27 states now reporting the disease.
All three of the new cases in the states were linked to international travel, according to state health officials.
The Department of Health in Louisiana said the individual who tested positive was not vaccinated and will remain in isolation until they are no longer infectious. The patient is in the greater New Orleans area.
A child in Virginia is the state's first case of measles this year, the Virginia Department of Health confirmed. The child's vaccination status is unknown.
'This first case of measles in Virginia this year is a reminder of how easily this highly contagious disease can spread, particularly with international travel,' the department's epidemiologist Laurie Forlano said. 'Vaccination remains our best defense against measles and is safe and highly effective at protecting people and preventing outbreaks. We urge Virginians, especially those planning to travel, to check their vaccination status, talk to their health care provider, and get the MMR vaccine if needed.'
In Missouri, the first case detected in the state is also a child whose vaccination status has not yet been verified by officials.
'There is no indication of widespread exposure as this person was diagnosed soon after arrival to Taney County,' the state health department said. 'Exposure is believed to be limited, and known contacts have been identified and contacted.'
Confirmed cases across the U.S. now stand at 800, the Centers for Disease Control and Prevention said Friday. It is nearly three times the total number of 285 cases reported in 2024, according to CDC data.
Cases are most prevalent in Texas, where two school-aged children have died from the disease. A 6-year-old girl from Gaines County, the center of the outbreak, died in February, the first measles death in the U.S. in a decade. An 8-year-old girl from the same town, Seminole, died earlier this month. Out of 800 cases, 597 are in West Texas.
Earlier this month Health Secretary Robert F. Kennedy Jr, who rose to prominence as an anti-vaccine advocate, met with the family of the 8-year-old girl who died from the disease.
Kennedy's inconsistent and unclear message on the measles vaccines has made the outbreaks difficult to contain, experts say.
He has occasionally endorsed the measles, mumps and rubella vaccine as 'effective,' but also continues to raise safety concerns about the shots in other statements. In a CBS interview last week, he claimed the vaccines were 'not safety tested.'
That approach has been the biggest flaw of the government's response, said Dr. Carlos del Rio, past president of the Infectious Diseases Society of America.
'Imagine if the captain of the Titanic had told you that you need to be careful about lifeboats and think about other opportunities,' del Rio said.
Trials were conducted on thousands of children before the vaccine was approved for use in the 1960s. The federal government has since used medical records to continue to monitor for side effects from use in millions of people since.
Meanwhile, lawmakers in Texas and about two-thirds of states have introduced legislation this year that would make it easier to opt out of vaccines or otherwise put up barriers to ensuring more people get shots, according to an analysis by The Associated Press. That further undercuts efforts to keep infectious diseases at bay, health officials said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
2 hours ago
- The Guardian
Assisted dying adverts to be banned if service legalised, Kim Leadbeater says
Adverts promoting assisted dying services will be banned if the procedure is made law under a new amendment, the MP sponsoring the bill has said. Labour's Kim Leadbeater said adverts promoting an assisted death as an option for terminally ill people would not be allowed. She will table an amendment prohibiting such advertising when the bill returns to the Commons on Friday, as well as an amendment that would require the Department of Health and Social Care to undertake an assessment of the state of palliative care. In a letter to MPs, Leadbeater said there was a 'wide consensus' that advertising the procedure should not be permitted. Adverts in other countries including Belgium and the Netherlands have received widespread backlashes for appearing to promote assisted dying as a preferable option. 'I have worked with colleagues on both sides of the debate and I believe there is wide consensus that if assisted dying does become legal, we wouldn't want to see it promoted through advertising,' Leadbeater said in her letter. 'There is also widespread consensus and support for improvements in palliative care. It is not a choice between assisted dying or palliative care – I firmly believe we should take a holistic approach to choice and care for terminally ill people.' Leadbeater said she was still meeting and hearing from MPs about ways the bill could be improved. 'One area where supporters and opponents, both in parliament and in the country, agree is that if we are to pass this legislation it should be the best and safest bill possible. I'm confident it can and will be,' she wrote. She said the bill would have received up to 200 hours of consideration if it passes the House of Lords, 'placing it among the most heavily scrutinised bills in recent times'. Other amendments tabled by Leadbeater include a clause on the regulation of substances used to hasten the death of patients who choose an assisted death. The bill would allow those with less than six months to live, who are terminally ill and of sound mind, to have an assisted death. There is relatively little detail on what that would mean in terms of the procedure contained in the bill. There would also be extra duties on the health secretary to consult people with learning disabilities, providers of health and care services including palliative and end of life care, and people with protected characteristics – such as race, religion and belief. Leadbeater said she would back an amendment from the Liberal Democrat MP Munira Wilson – an opponent of the bill – for the government to undertake a detailed assessment of the state of palliative and end of life care. 'I fully support it. It is not a choice between assisted dying or palliative care – I firmly believe we should take a holistic approach to choice and care for terminally ill people,' Leadbeater said. 'This amendment also has the backing of Marie Curie and others in the charitable and end of life sector.' MPs will have their final vote on the bill next Friday with more than a dozen believed to have switched sides to oppose the bill, though at least three have moved to support it. On Wednesday the Labour party chair, Ellie Reeves, who abstained at the last vote, confirmed she would vote for the bill. But two others, including the former health minister Andrew Gwynne and the Labour MP Paul Foster, suggested they would now oppose the legislation.
The Herald Scotland
10 hours ago
- The Herald Scotland
RFK Jr. bring on eight members on vaccine panel
"All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense," wrote Kennedy in a post on X on June 11. "They have each committed to demanding definitive safety and efficacy data before making any new vaccine recommendations." The Advisory Committee for Immunization Practices makes recommendations on the safety, efficacy and clinical need of vaccines to the Centers for Disease Control and Prevention. It comprises medical and public health experts who develop recommendations on the use of vaccines in the civilian population of the United States. "The committee will review safety and efficacy data for the current schedule as well," noted Kennedy, who has a history of controversial views on vaccines. Dr. Paul A. Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia and a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee, previously told USA TODAY that Kennedy was "fixing a problem that doesn't exist," by overhauling the committee. Picking members for the committee generally involves a three- to four-month vetting process by the CDC. Offit said he would "presumably pick people who are like-minded, and I think that will shake confidence in this committee." The list of appointees includes: Dr. Joseph R. Hibbeln, a psychiatrist and neuroscientist with a career in clinical research, public health policy, and federal service; Dr. Martin Kulldorff, a biostatistician and epidemiologist formerly at Harvard Medical School and a leading expert in vaccine safety and infectious disease surveillance; Retsef Levi, a professor of operations management at the MIT Sloan School of Management who specializes in healthcare analytics; Dr. Robert W. Malone, a physician-scientist and biochemist who claims to be the inventor of mRNA vaccine technology and has said spike proteins from COVID-19 mRNA vaccines often causepermanent damage to children's vital organs; Dr. Cody Meissner, a professor of pediatrics at the Geisel School of Medicine at Dartmouth; Dr. James Pagano, an emergency medicine physician; Vicky Pebsworth, who holds a doctorate in public health and nursing from the University of Michigan and Michael A. Ross, a clinical professor of Obstetrics and Gynecology at George Washington University and Virginia Commonwealth University. and will replace them with new members, a move that the Trump administration's critics warned would create public distrust around the government's role in promoting public health.
The Independent
20 hours ago
- The Independent
Government can hit NHS waiting times targets despite scepticism, says Reeves
The Chancellor has insisted the Government can hit its NHS waiting times targets despite scepticism from some leaders. Speaking after her spending review, Rachel Reeves said the Government was confident it could hit pledges set down by the Prime Minister last year. Sir Keir Starmer said in December the NHS will carry out 92% of routine operations within 18 weeks by March 2029. However, in March this year, the NHS waiting list for hospital treatment in England rose for the first time in seven months. The Times has also reported that internal Department of Health modelling shows the NHS is on course to hit only about 80% by the end of the parliament, with officials suggesting anything above that is overly optimistic. Asked about the pledge on Wednesday afternoon, Ms Reeves told reporters: 'We've already delivered around three-and-a-half million additional appointments since we came to office last July. 'Waiting lists are already down by 200,000 so we are confident that we can meet our plan for change commitments because of the 3% annual increase in funding for the National Health Service. 'On top of that of course, we're investing in capital spending in the NHS, including in more scanners, but also investment in the NHS digital app to make it easier for patients to access information, to book services, to take some of the costs out of the bureaucracy, as well in running our health service.' Earlier, the 3% increase in real terms for the health service per year in the spending review was welcomed by health leaders but there were warnings it is not enough. Matthew Taylor, chief executive of the NHS Confederation, which represents all health organisations, said the NHS funding boost was welcome, 'given the precarious state of public finances and will help the NHS to cope with rising demand from an aging population, often with multiple or more complex physical and mental health conditions'. But he warned 'difficult decisions will still need to be made as this additional £29 billion won't be enough to cover the increasing cost of new treatments, with staff pay likely to account for a large proportion of it'. He added: 'So, on its own, this won't guarantee that waiting time targets are met.' Mr Taylor said NHS leaders will need continued backing from the Government to redesign services and balance budgets. 'That means getting political backing when some services are redesigned or cut, including moving hospital services into the community and closer to people's homes as part of the Government's three shifts,' he said. He added that the 'flat settlement' from the Chancellor 'continues to leave a major shortfall in capital funding, and it also fails to lift the ban on private investment that is required to boost NHS capital funding'. There is currently an almost £14 billion maintenance backlog bill to repair NHS hospitals and buildings. Mr Taylor said those issues needed to be addressed in the upcoming national infrastructure strategy and 10-year plan for the health service. Government documents accompanying the spending review show that, on average, from 2023-24 to 2028-29, the NHS in England will receive 3% real terms growth in day-to-day spending, equivalent to a £29 billion real terms increase in annual budgets. The Department of Health and Social Care (DHSC) budget will increase by £2.3 billion in real terms by 2029-30, compared with 2023-24, 'representing a more than 20% real terms increase by the end of the spending review period', the documents said. Overall, the figures suggest DHSC spending will rise 2.8%, though this is less than the average 3.6% in recent years. Sarah Woolnough, chief executive of the King's Fund charity, said the 2.8% average increase in DHSC spending – or 3% for day-to-day NHS spending – 'will have been hard-fought for in the spending round negotiations, despite still being lower than the historical average the NHS has received over recent years'. She added: 'We know there are already trade-offs happening in the NHS due to tight finances. 'The Chancellor said she wants the public to have an NHS there when they need it. 'It is hard to see how all the things she mentions: faster ambulance times; more GP appointments; and adequate mental health services and more; can be met on this settlement alone. 'Particularly when large parts of this additional funding will be absorbed by existing rising costs, such as the higher cost of medicines, which are currently being negotiated, and covering staff pay deals.' According to spending review documents, the Government expects the NHS to deliver 2% productivity growth each year, 'unlocking £17 billion savings over three years' to reinvest back into the NHS to improve patient care. The Government will also invest up to £10 billion in NHS technology and digital transformation by 2028‑29, the documents showed. NHS England boss Sir Jim Mackey, speaking at the NHS ConfedExpo conference in Manchester, said the NHS has done 'really well relative to other parts of the public service'. He added: 'But we all know it's never enough because of the scale of advancement, all the ambition, all things we want to do, the day-to-day cost pressures we're trying to get on top of, etc. 'We're always going to be in a world where we want more money, but I think everyone's starting to accept and understand that we've got what the country can afford to give us. 'We really need to get better value for that money – it is broadly the equivalent of the GDP of Portugal, so it's a huge amount of money by any standards.' NHS England has already budgeted a 2.8% increase in pay for staff in 2025-26, but many leaders the King's Fund spoke to were worried about funding pay rises above this amount. After the spending review, Royal College of Nursing (RCN) general secretary, Professor Nicola Ranger, said staff will now decide whether the 3.6% pay rise offered by the Government is enough. She added: 'Against a backdrop of other cuts, nursing staff will see the NHS being protected but not transformed by today's spending plans. 'When the Government lays out its vision for the future of the NHS and its workforce, it must say how it intends to reverse collapsing student recruitment, boost retention and deliver urgent, structural reform to nursing pay.' Nuffield Trust senior policy analyst, Sally Gainsbury, said: 'Compared to the settlements for other departments – from policing to education – the NHS deal looks generous. 'But seen in the context of all the promises made by the Government to the British people – to drive down waiting lists, shift care closer to home, rapidly improve tech – and the commitments to meet staff pay demands and rising costs of new drugs, today's settlement soon melts away. 'With capital funding staying flat in real terms for the rest of the spending review period, it will be difficult for the NHS to invest in the technology and facility upgrades it needs to meet the Government's ambitious productivity targets.'
